Caliway Successfully Lists on Taipei Exchange Following IPO

NEW TAIPEI CITY, Oct. 2, 2024 /PRNewswire/ — Caliway Biopharmaceuticals (Caliway) announced the successful completion of its initial public offering (IPO) and up-listing from the Emerging Stock Market to the Taipei Exchange (TWSE-6919). The round, which concluded on September 24,…